Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Gross Margin Growth (5y) (2014 - 2026)

Analysis

Bio-Techne (TECH) Gross Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -211.00
Mar 31, 2026 -221.00
Dec 31, 2025 -264.00
Sep 30, 2025 -180.00
Jun 30, 2025 -172.00
Mar 31, 2025 105.00
Dec 31, 2024 -37.00
Sep 30, 2024 -139.00
Jun 30, 2024 -49.00
Mar 31, 2024 2.00
Dec 31, 2023 2.00
Sep 30, 2023 85.00
Jun 30, 2023 15.00
Mar 31, 2023 149.00
Dec 31, 2022 146.00
Sep 30, 2022 -107.00
Jun 30, 2022 413.00
Mar 31, 2022 226.00
Dec 31, 2021 134.00
Sep 30, 2021 -54.00